001     127034
005     20240228140902.0
024 7 _ |a 10.1074/jbc.R115.640359
|2 doi
024 7 _ |a pmid:25957409
|2 pmid
024 7 _ |a pmc:PMC4498054
|2 pmc
024 7 _ |a 0021-9258
|2 ISSN
024 7 _ |a 1083-351X
|2 ISSN
024 7 _ |a altmetric:55114445
|2 altmetric
037 _ _ |a DKFZ-2017-03060
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Lowery, Jason
|b 0
245 _ _ |a Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function.
260 _ _ |a Bethesda, Md.
|c 2015
|b Soc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1508835383_29222
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Intermediate filaments (IFs) are composed of one or more members of a large family of cytoskeletal proteins, whose expression is cell- and tissue type-specific. Their importance in regulating the physiological properties of cells is becoming widely recognized in functions ranging from cell motility to signal transduction. IF proteins assemble into nanoscale biopolymers with unique strain-hardening properties that are related to their roles in regulating the mechanical integrity of cells. Furthermore, mutations in the genes encoding IF proteins cause a wide range of human diseases. Due to the number of different types of IF proteins, we have limited this short review to cover structure and function topics mainly related to the simpler homopolymeric IF networks composed of vimentin, and specifically for diseases, the related muscle-specific desmin IF networks.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Desmin
|2 NLM Chemicals
650 _ 7 |a Intermediate Filament Proteins
|2 NLM Chemicals
650 _ 7 |a Vimentin
|2 NLM Chemicals
700 1 _ |a Kuczmarski, Edward R
|b 1
700 1 _ |a Herrmann, Harald
|0 P:(DE-He78)7892a89fee19b8e3912c7423d660765d
|b 2
|u dkfz
700 1 _ |a Goldman, Robert D
|b 3
773 _ _ |a 10.1074/jbc.R115.640359
|g Vol. 290, no. 28, p. 17145 - 17153
|0 PERI:(DE-600)1474604-9
|n 28
|p 17145 - 17153
|t The journal of biological chemistry
|v 290
|y 2015
|x 1083-351X
909 C O |o oai:inrepo02.dkfz.de:127034
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)7892a89fee19b8e3912c7423d660765d
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J BIOL CHEM : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)B065-20160331
|k B065
|l Funktionelle Zellarchitektur
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B065-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21